NCT00242177View on ClinicalTrials.gov

Pilot Test of ACTOS in Multiple Sclerosis: Safety and Tolerability

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 31, 2003

Study Completion Date

October 31, 2005

Conditions
Multiple Sclerosis, Relapsing-Remitting
Interventions
DRUG

ACTOS (Pioglitazone)

Trial Locations (1)

60612

University of Illinois at Chicago, Chicago

All Listed Sponsors
collaborator

Takeda Pharmaceuticals North America, Inc.

INDUSTRY

lead

University of Illinois at Chicago

OTHER

NCT00242177 - Pilot Test of ACTOS in Multiple Sclerosis: Safety and Tolerability | Biotech Hunter | Biotech Hunter